VERU INC. Payment for Debt Extinguishment or Debt Prepayment Cost
VERU INC. (VERU) reported Payment for Debt Extinguishment or Debt Prepayment Cost of $0 for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtExtinguishmentCosts · last filed 2026-08-10
- VERU INC. payment for debt extinguishment or debt prepayment cost for the quarter ending 2026-06-30 was $0.00.
- VERU INC. payment for debt extinguishment or debt prepayment cost for the quarter ending 2026-03-31 was $0.00.
- VERU INC. payment for debt extinguishment or debt prepayment cost for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- VERU INC. payment for debt extinguishment or debt prepayment cost for the quarter ending 2025-09-30 was $0.00.
- VERU INC. payment for debt extinguishment or debt prepayment cost for fiscal 2025 was $4.22M.
- VERU INC. payment for debt extinguishment or debt prepayment cost for fiscal 2024 was $0.00.
| Period end | Payment for Debt Extinguishment or Debt Prepayment Cost 3 month | Payment for Debt Extinguishment or Debt Prepayment Cost 6 month | Payment for Debt Extinguishment or Debt Prepayment Cost 9 month | Payment for Debt Extinguishment or Debt Prepayment Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $0.00 10-Q · filed 2026-08-10 | $0.00 derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | $0.00 10-Q · filed 2026-05-13 | $0.00 derived: sum of 3 quarters · filed 2026-05-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $0.00 10-Q · filed 2026-02-11 | $0.00 derived: sum of 2 quarters · filed 2026-02-11 | $0.00 derived: sum of 3 quarters · filed 2026-08-10 | $0.00 derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $0.00 derived: sum of 3 quarters · filed 2026-08-10 | $4.22M 10-K · filed 2025-12-17 |
| 2025-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $4.22M 10-Q · filed 2026-08-10 | $4.22M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | $4.22M 10-Q · filed 2026-05-13 | $4.22M derived: sum of 3 quarters · filed 2026-05-13 | $4.22M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $4.22M 10-Q · filed 2026-02-11 | $4.22M derived: sum of 2 quarters · filed 2026-02-11 | $4.22M derived: sum of 3 quarters · filed 2026-02-11 | $4.22M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $0.00 derived: sum of 2 quarters · filed 2025-12-17 | $0.00 derived: sum of 3 quarters · filed 2025-12-17 | $0.00 10-K · filed 2025-12-17 |
| 2024-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-12 | $0.00 derived: sum of 2 quarters · filed 2025-08-12 | $0.00 10-Q · filed 2025-08-12 | |
| 2024-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-08 | $0.00 10-Q · filed 2025-05-08 | ||
| 2023-12-31 | $0.00 10-Q · filed 2025-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |